Monday, February 27, 2017 2:27:55 PM
Looks like Belcher was the attorney who received the 1,250 Preferred C shares ($1.25 Million valuation). So if these running totals in the most recent DECN 9/30/2016 OTC filing are correct, Belcher converted 140, so he has 1,110 remaining.
PREFERRED C STOCK
1/4/2012 New Issuance-Michael Belcher 1,250
10/28/2013 Conversion-Michael Belcher (70)
2/18/2014 Conversion-Michael Belcher (70)
https://www.otcmarkets.com/financialReportViewer?symbol=DECN&id=162731
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM